We are live on ! Find out more
HTC

Hershey Trust Company Portfolio holdings

AUM $11.8B
1-Year Est. Return 0.75%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+0.75%
3 Year Est. Return
-0.55%
5 Year Est. Return
-0.68%
10 Year Est. Return
+3.33%
AUM
$10.4B
AUM Growth
-$253M
Cap. Flow
+$54.5M
Cap. Flow %
0.52%
Top 10 Hldgs %
99.8%
Holding
46
New
9
Increased
9
Reduced
3
Closed
16

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$25.1M
2
PDD icon
Pinduoduo
PDD
+$5.15M
3
TDOC icon
Teladoc Health
TDOC
+$3.88M
4
UBER icon
Uber
UBER
+$3.02M
5
ABNB icon
Airbnb
ABNB
+$1.96M

Top Sells

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$2.17M
2
RPTX
Repare Therapeutics
RPTX
+$771K
3
CRWD icon
CrowdStrike
CRWD
+$393K
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$373K
5
EB
Eventbrite
EB
+$330K

Sector Composition

Rank Sector Weight
1 Healthcare 0.1%
2 Consumer Discretionary 0.1%
3 Consumer Staples 0.08%
4 Technology 0.05%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALGS icon
26
Aligos Therapeutics
ALGS
$26.3M
$94K ﹤0.01%
243
– –
QNCX icon
27
Quince Therapeutics
QNCX
$21.5M
$63K ﹤0.01%
+3
New +$47.7K
ADVM
28
DELISTED
Adverum Biotechnologies
ADVM
– –
-371
Closed -$13K
APRE icon
29
Aprea Therapeutics
APRE
$7.69M
– –
-491
Closed -$48K
BDTX icon
30
Black Diamond Therapeutics
BDTX
$95.1M
– –
-12,836
Closed -$156K
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$8.88B
– –
-19,778
Closed -$373K
CRWD icon
32
CrowdStrike
CRWD
$183B
– –
-6,252
Closed -$393K
EB
33
DELISTED
Eventbrite
EB
– –
-17,343
Closed -$330K
NOAH
34
Noah Holdings
NOAH
$590M
– –
-253
Closed -$12K
NRIX icon
35
Nurix Therapeutics
NRIX
$2.45B
– –
-8,807
Closed -$234K
PACB icon
36
Pacific Biosciences
PACB
$435M
– –
-5,258
Closed -$184K
RLAY icon
37
Relay Therapeutics
RLAY
$4B
– –
-59,360
Closed -$2.17M
RPTX
38
DELISTED
Repare Therapeutics
RPTX
– –
-24,728
Closed -$771K
EGRX
39
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-2,138
Closed -$92K
OYST
40
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-8,861
Closed -$152K
1
2

Similar funds

VA
Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
VIA
Vantagepoint Investment Advisers Washington, District of Columbia $11.8B AUM 9.48% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
PI
PineBridge Investments New York $11.9B AUM 23.42% 1-Year Est. Return
UE
Unisphere Establishment Vaduz, Liechtenstein $11.9B AUM 6.1% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $11.9B AUM 10.84% 1-Year Est. Return

Hershey Trust Company's Q3 2021 Portfolio in Review

As of Q3 2021, Hershey Trust Company held 46 positions worth $10.4B, down 2.4% from $10.7B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hershey Trust Company's Q3 2021 filing shows 9 new, 9 increased, 3 reduced and 16 closed positions. Its largest new stake was Uber: 69,052 shares worth $3.09M. The largest sale was Relay Therapeutics, an estimated $2.17M.

By sector, the portfolio is most concentrated in Healthcare at 0.1% of assets, down from 0.11% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Hershey Trust Company's largest Q3 2021 buy was Uber: 69,052 shares worth $3.09M.
  • Hershey Trust Company added most to iShares Russell 2000 ETF in Q3 2021, an estimated $25.1M increase.
  • Hershey Trust Company's biggest Q3 2021 reduction was C3.ai, cutting an estimated $203K.
  • Hershey Trust Company fully exited Relay Therapeutics in Q3 2021, selling an estimated $2.17M.
  • Hershey Trust Company's ten largest holdings make up 100% of its $10.4B portfolio in Q3 2021.
  • Hershey Trust Company opened 9 new positions and closed 16 in Q3 2021.
  • Hershey Trust Company's portfolio value fell 2.4% quarter-over-quarter to $10.4B.

Based on Hershey Trust Company's 13F filing for Q3 2021, filed 12 Nov 2021.